Chengappa KNR - Search Results

1

Effects of a standardized extract of Withania somnifera (Ashwagandha) on depression and anxiety symptoms in persons with schizophrenia participating in a randomized, placebo-controlled clinical trial.

Gannon JM, Brar J, Rai A, Chengappa KNR. Gannon JM, et al. Among authors: chengappa knr. Ann Clin Psychiatry. 2019 May;31(2):123-129. Ann Clin Psychiatry. 2019. PMID: 31046033 Clinical Trial.

2

Should chronic treatment-refractory akathisia be an indication for the use of clozapine in schizophrenic patients?

Levin H, Chengappa KN, Kambhampati RK, Mahdavi N, Ganguli R. Levin H, et al. J Clin Psychiatry. 1992 Jul;53(7):248-51. J Clin Psychiatry. 1992. PMID: 1353492

3

Altered interleukin-2 production in schizophrenia: association between clinical state and autoantibody production.

Ganguli R, Brar JS, Solomon W, Chengappa KN, Rabin BS. Ganguli R, et al. Psychiatry Res. 1992 Nov;44(2):113-23. doi: 10.1016/0165-1781(92)90046-6. Psychiatry Res. 1992. PMID: 1480677

4

Emergence of obsessive compulsive symptoms during treatment with clozapine.

Baker RW, Chengappa KN, Baird JW, Steingard S, Christ MA, Schooler NR. Baker RW, et al. J Clin Psychiatry. 1992 Dec;53(12):439-42. J Clin Psychiatry. 1992. PMID: 1487472

5

Serum interleukin-6 concentration in schizophrenia: elevation associated with duration of illness.

Ganguli R, Yang Z, Shurin G, Chengappa KN, Brar JS, Gubbi AV, Rabin BS. Ganguli R, et al. Psychiatry Res. 1994 Jan;51(1):1-10. doi: 10.1016/0165-1781(94)90042-6. Psychiatry Res. 1994. PMID: 7910974

6

Assessment of changes in both weight and frequency of use of medications for the treatment of gastrointestinal symptoms among clozapine-treated patients.

John JP, Chengappa KN, Baker RW, Gupta B, Mortimer MT. John JP, et al. Ann Clin Psychiatry. 1995 Sep;7(3):119-25. doi: 10.3109/10401239509149038. Ann Clin Psychiatry. 1995. PMID: 8646271

7

Clozapine reduces severe self-mutilation and aggression in psychotic patients with borderline personality disorder.

Chengappa KN, Ebeling T, Kang JS, Levine J, Parepally H. Chengappa KN, et al. J Clin Psychiatry. 1999 Jul;60(7):477-84. doi: 10.4088/jcp.v60n0710. J Clin Psychiatry. 1999. PMID: 10453803

8

Response to placebo among bipolar I disorder patients experiencing their first manic episode.

Chengappa KN, Tohen M, Levine J, Jacobs T, Thase ME, Sanger TM, Kupfer DJ. Chengappa KN, et al. Bipolar Disord. 2000 Dec;2(4):332-5. doi: 10.1034/j.1399-5618.2000.020407.x. Bipolar Disord. 2000. PMID: 11252646 Clinical Trial.

This study details the treatment response of six first-episode manic patients who participated in a previously reported study of 139 subjects comparing olanzapine to placebo in bipolar I mania (Tohen M, Sanger TM, McElroy SL, Tollefson GD, Chengappa KNR, Daniel DG. …

This study details the treatment response of six first-episode manic patients who participated in a previously reported study of 139 subject …

9

Inositol as an add-on treatment for bipolar depression.

Chengappa KN, Levine J, Gershon S, Mallinger AG, Hardan A, Vagnucci A, Pollock B, Luther J, Buttenfield J, Verfaille S, Kupfer DJ. Chengappa KN, et al. Bipolar Disord. 2000 Mar;2(1):47-55. doi: 10.1034/j.1399-5618.2000.020107.x. Bipolar Disord. 2000. PMID: 11254020 Clinical Trial.

10

Bupropion sustained release as a smoking cessation treatment in remitted depressed patients maintained on treatment with selective serotonin reuptake inhibitor antidepressants.

Chengappa KN, Kambhampati RK, Perkins K, Nigam R, Anderson T, Brar JS, Vemulapalli HK, Atzert R, Key P, Kang JS, Levine J. Chengappa KN, et al. J Clin Psychiatry. 2001 Jul;62(7):503-8. doi: 10.4088/jcp.v62n07a01. J Clin Psychiatry. 2001. PMID: 11488359 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results